Oruka Therapeutics Inc (ORKA)

R&D Expense Growth

48.42%

Quarterly · Period ending:

ORKA logo

ORKA R&D Expense Growth

Latest reported48.42%
ORKA Quarterly R&D Growth (QoQ) (0.00% → 48.42%)
High-resolution chart · PNG

ORKA r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Oruka Therapeutics Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
48.42%
5.445%
-4.6502%
20.3471%
20.8883%
-38.3635%
25.8286%
37.5837%
11,216.9697%
251.0638%
-85.4037%
26.7717%
-34.8718%
46.6165%
-50.1873%
-46.3317%
-54.3369%
-44.7095%
14.6306%
-3.8859%
24.3741%
-10.2372%
204.8525%
182.5269%
1.9178%
-4.9479%
10.6628%
-21.1364%
-33.5347%
5.92%
-15.5405%
-35.8752%
-32.907%
-39.3084%
-18.75%
-22.6264%
38.8786%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.